{"schema_version":"1","generated_at":"2026-11-22T00:09:33.368Z","data_as_of":null,"url":"https://www.findmykol.com/kol/douglas-goodin","json_url":"https://www.findmykol.com/kol/douglas-goodin/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"douglas-goodin","name":"Douglas Goodin","specialty":"Neurology","specialty_raw":"Neurology","therapeutic_area":"Neurology","therapeutic_areas":["Neurology"],"institution":"University of California, San Francisco","institution_url":"https://www.findmykol.com/institution/university-of-california-san-francisco","city":"San Francisco","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"on_file":["npi","orcid","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Douglas Goodin is a Neurology physician affiliated with University of California, San Francisco. OpenAlex indexes 251 publications with 17,658 citations (h-index 68). By OpenAlex citation count, this profile ranks in the top 10% of Neurology profiles in the FindMyKOL directory.","overview":null,"focus":{"indications":[],"research_topics":["Neurology"]},"scholarship":{"works_count":251,"cited_by_count":17658,"h_index":68,"latest_activity_year":2025,"citation_standing":{"top_percent":10,"cohort":"Neurology","method":"https://www.findmykol.com/about#citation-standing"},"source":"works"},"payments":{"company_count":11,"program_years":{"first":2021,"last":null},"rows_total":29,"shown":3,"withheld":26,"rows":[{"payer":"Amgen Inc.","program_year":2025,"amount_usd":16736.27,"payment_count":18},{"payer":"Novartis Pharmaceuticals Corporation","program_year":2025,"amount_usd":89.1,"payment_count":3},{"payer":"Genentech, Inc.","program_year":2025,"amount_usd":47.56,"payment_count":1}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":4,"areas_shown":3,"areas":[{"area":"Nervous system","share_pct":51,"classes_total":9,"classes":[{"class":"Gabapentinoids","setting":"prescribed","share_pct":18.9,"drugs":[{"name":"Gabapentin","share_pct":80.7},{"name":"Pregabalin","share_pct":19.3}],"max_beneficiaries":null},{"class":"Potassium Channel Blocker","setting":"prescribed","share_pct":7.5,"drugs":[{"name":"Dalfampridine Er","share_pct":100}],"max_beneficiaries":13}]},{"area":"Cancer & immunology","share_pct":33.1,"classes_total":4,"classes":[{"class":"Other immunostimulants","setting":"prescribed","share_pct":15.7,"drugs":[{"name":"Copaxone","share_pct":67.7},{"name":"Glatopa","share_pct":32.3}],"max_beneficiaries":null},{"class":"Sphingosine 1-phosphate Receptor Modulator","setting":"prescribed","share_pct":10.8,"drugs":[{"name":"Fingolimod","share_pct":58.8},{"name":"Mayzent","share_pct":41.2}],"max_beneficiaries":null}]},{"area":"Musculoskeletal","share_pct":13.4,"classes_total":1,"classes":[{"class":"gamma-Aminobutyric Acid-ergic Agonist","setting":"prescribed","share_pct":13.4,"drugs":[{"name":"Baclofen","share_pct":100}],"max_beneficiaries":20}]}],"care_setting":{"dominant":"office","data_year":2023,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis","year":2021,"journal":"Annals of Neurology","source_url":"https://doi.org/10.1002/ana.26281","status":"verified"},{"title":"Silent progression in disease activity–free relapsing multiple sclerosis","year":2019,"journal":"Annals of Neurology","source_url":"https://doi.org/10.1002/ana.25463","status":"verified"},{"title":"The epidemiology of multiple sclerosis","year":2016,"journal":"Handbook of clinical neurology","source_url":"https://doi.org/10.1016/b978-0-12-802973-2.00011-2","status":"verified"},{"title":"Long‐term evolution of multiple sclerosis disability in the treatment era","year":2016,"journal":"Annals of Neurology","source_url":"https://doi.org/10.1002/ana.24747","status":"verified"},{"title":"Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b","year":2015,"journal":"JAMA Neurology","source_url":"https://doi.org/10.1001/jamaneurol.2015.2742","status":"verified"}],"source":"works"},"similar":[{"name":"Kristine Yaffe","slug":"kristine-yaffe","institution":"University of California, San Francisco","specialty":"Geriatric Psychiatry","url":"https://www.findmykol.com/kol/kristine-yaffe","json_url":"https://www.findmykol.com/kol/kristine-yaffe/profile.json"},{"name":"Peter Carroll","slug":"peter-carroll","institution":"University of California, San Francisco","specialty":"Urology","url":"https://www.findmykol.com/kol/peter-carroll","json_url":"https://www.findmykol.com/kol/peter-carroll/profile.json"},{"name":"Steven Deeks","slug":"steven-deeks","institution":"University of California, San Francisco","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/steven-deeks","json_url":"https://www.findmykol.com/kol/steven-deeks/profile.json"},{"name":"Michael Shlipak","slug":"michael-shlipak","institution":"University of California, San Francisco","specialty":"Internal Medicine","url":"https://www.findmykol.com/kol/michael-shlipak","json_url":"https://www.findmykol.com/kol/michael-shlipak/profile.json"},{"name":"Bruce Miller","slug":"bruce-miller","institution":"University of California, San Francisco (UCSF)","specialty":"Neurology","url":"https://www.findmykol.com/kol/bruce-miller","json_url":"https://www.findmykol.com/kol/bruce-miller/profile.json"},{"name":"David Knopman","slug":"david-knopman","institution":"Mayo Clinic Rochester","specialty":"Neurology","url":"https://www.findmykol.com/kol/david-knopman","json_url":"https://www.findmykol.com/kol/david-knopman/profile.json"},{"name":"Brett Kissela","slug":"brett-kissela","institution":"Medical College of Wisconsin","specialty":"Neurology","url":"https://www.findmykol.com/kol/brett-kissela","json_url":"https://www.findmykol.com/kol/brett-kissela/profile.json"},{"name":"Richard Lipton","slug":"richard-lipton","institution":"Albert Einstein College of Medicine","specialty":"Neurology","url":"https://www.findmykol.com/kol/richard-lipton","json_url":"https://www.findmykol.com/kol/richard-lipton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":26,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}